Current Liabilities Veränderung Datum
AbbVie USD 36.4B 2.35B 2025-03
Abbott USD 13.44B 435M 2025-06
ALKERMES USD 505.96M 62.23M 2025-06
Amgen USD 20.48B 2.53B 2025-06
AstraZeneca USD 33.54B 4.41B 2025-06
Biogen USD 3.18B 2.11B 2025-06
BioMarin Pharmaceutical USD 684.25M 56.03M 2025-06
Bristol-Myers Squibb USD 27.53B 3.46B 2025-06
Eisai JPY 411.61B 39.31B 2025-06
Eli Lilly USD 30.07B 1.69B 2025-03
Gilead Sciences USD 12B 279M 2024-12
GlaxoSmithKline GBP 20.38B 453M 2025-06
J&J USD 56.9B 6.58B 2025-03
Medtronic USD 12.88B 1.04B 2025-04
Merck USD 25.17B 3.25B 2025-03
Neurocrine Biosciences USD 546.3M 23.4M 2025-06
Novartis USD 31.71B 95M 2025-06
Pacira USD 313.16M 1.57M 2025-06
Perrigo USD 1.07B 29.6M 2025-03
Pfizer USD 37.73B 1.27B 2025-06
Regeneron Pharmaceuticals USD 3.67B 100.4M 2025-06
Roche Holding CHF 27.02B 424M 2024-12
Sanofi 29.06B 3.16B 2025-06
UCB EUR 3.53B 731M 2024-12
Ultragenyx Pharmaceutical USD 293.24M 1.58M 2025-06
United Therapeutics USD 527.1M 194.4M 2025-06
Vertex Pharmaceuticals USD 4.14B 355.2M 2025-06
Zoetis USD 3.37B 19M 2025-06


AbbVie Aktuelle Verpflichtungen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.